Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
JoeV1973's Profile
Displaying 1-1 of 1 result(s).
NNLX Nanologix Inc
12/01/2020 10:32:56 PM
New to board not so new to NNLX, be (2)

Recent Articles

  • Government's New Investment Strategy: A Look at Key Stocks
  • Coinbase's Brian Armstrong Embraces Future of Crypto Rules
  • Intellistake Secures C$500,000 for Decentralized AI Initiative
  • Dowlais Group Finance Update: Key Trading Information
  • Spruce Biosciences Experiences Remarkable Stock Surge
  • Empowering Life Sciences: Key Insights from Optimum's Conference
  • Quod Financial Unveils Unity: Revolutionizing Trading Integration
  • Insight into EMERALD Study Design by Resolution Therapeutics
  • Eurocastle's Strategic Move: Release of Remaining Reserves
  • Epic Games' Major Victory Over Google Revolutionizes App Market
  • Trump’s Government Shutdown Standoff: A Look at Bipartisan Opportunities
  • Collaborative Innovation: ASUS ProArt Teams with GoPro
  • MuniFin's EUR 14.5 Million MTN Tap for Sustainable Investments
  • Heineken® Strengthens Commitment to Women's Football Until 2030
  • Municipality Finance Secures EUR 15 Million Financing Through MTN Program
  • Eurocastle's Strategic Shift: Unveiling Full Reserve Release
  • Understanding Director Shareholding Trends at Admiral Group
  • Bishop Street Underwriters Strengthens Global Position with Avid
  • Discover Unbeatable Deals on Narwal Vacuum Robots This Fall
  • Gary Black Highlights Tesla's Underutilized Brand Potential
  • Rising Greenwashing and Biodiversity Risks in Business Practices
  • Winbond Revolutionizes IP Management with Clarivate's IPfolio
  • Evolving Healthcare Trends in the UAE: Embracing Technology and Sustainability
  • TEKLYNX CENTRAL 8.0: A Comprehensive Solution for Labeling
  • ASUS ProArt and GoPro: Elevating Creativity with AI Innovation
  • Exploring Innovative Approaches to Cancer Treatment Strategies
  • Innovative Approaches in Lutetium-177 Therapeutics for mCRPC
  • Telia Lietuva Transforms Management for Enhanced Efficiency
  • Novaturas Updates Investors on Shareholding Developments
  • Cellectis Showcases Innovations in Non-Viral Gene Therapy at Congress
  • Market Climbs Higher Amid Increased Investor Optimism
  • Tilray Brands' Earning Forecasts: Analysts Weigh In for Q1
  • Future Growth of the Global Pharmaceutical Market Unveiled
  • Cellectis Unveils Advances in Gene Therapy at ESGCT Conference
  • Semler Scientific, Inc. Investors Invited to Join Class Action
  • Market Insights: Stocks to Watch for Growth Opportunities
  • Nel ASA Secures Key Order to Advance Green Hydrogen Projects
  • Investigation of Brightstar Global Solutions Over Data Breach Issues
  • Unlocking AI Potential: Yotta's Shakti Studio Revolutionizes Enterprise Solutions
  • Yotta's Shakti Studio Revolutionizes AI Adoption for All
  • Skanska Secures $148M Contract for Power Facility Project
  • Shell's Q3 2025 Outlook: Expectations and Key Highlights
  • Latest Developments at Amaroq Ltd.'s Nalunaq Gold Mine
  • Will Ethereum Surpass $5,000? Insights for 2025 Investors
  • Figma's Stock Soars with Exciting OpenAI Collaboration News
  • Electric Era Transforms EV Charging for Love's Travel Stops
  • Beactica Therapeutics Advances Development of BEA-17
  • Beactica Therapeutics Moves Forward with BEA-17 Development
  • Affordable Dental Care Initiatives Transform Community Access
  • Mobile Computer Market Expected to Reach $10.20 Billion by 2033
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site